Barker AF, Bergeron A, Rom WN, Hertz MI. Obliterative bronchiolitis. N Engl J Med. 2014;370:1820–8. https://doi.org/10.1056/NEJMra1204664.

Article  CAS  PubMed  Google Scholar 

Williams KM. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Blood. 2017;129:448–55. https://doi.org/10.1182/blood-2016-08-693507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bergeron A, Cheng GS. Bronchiolitis obliterans syndrome and other late pulmonary complications after allogeneic hematopoietic stem cell transplantation. Clin Chest Med. 2017;38:607–21. https://doi.org/10.1016/j.ccm.2017.07.003.

Article  PubMed  Google Scholar 

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transpl. 2015;21:389–401.e1. https://doi.org/10.1016/j.bbmt.2014.12.001.

Article  Google Scholar 

Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56. https://doi.org/10.1016/j.bbmt.2005.09.004.

Article  Google Scholar 

Fujii N, Nakase K, Asakura S, Matsuo K, Nawa Y, Sunami K, et al. Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group. Int J Hematol. 2014;99:644–51. https://doi.org/10.1007/s12185-014-1556-4.

Article  PubMed  Google Scholar 

Au BK, Au MA, Chien JW. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2011;17:1072–8. https://doi.org/10.1016/j.bbmt.2010.11.018.

Article  Google Scholar 

Gazourian L, Coronata AM, Rogers AJ, Weinhouse GL, Soiffer RJ, Antin JH, et al. Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. Respir Med. 2013;107:276–83. https://doi.org/10.1016/j.rmed.2012.11.002.

Article  PubMed  Google Scholar 

Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, et al. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transpl. 2013;48:819–24. https://doi.org/10.1038/bmt.2012.241.

Article  CAS  Google Scholar 

Kuzmina Z, Krenn K, Petkov V, Kormoczi U, Weigl R, Rottal A, et al. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome. Blood. 2013;121:1886–95. https://doi.org/10.1182/blood-2012-06-435008.

Article  CAS  PubMed  Google Scholar 

Chien JW, Duncan S, Williams KM, Pavletic SZ. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2010;16:S106–114. https://doi.org/10.1016/j.bbmt.2009.11.002.

Article  Google Scholar 

Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transpl. 2003;9:657–66. https://doi.org/10.1016/s1083-8791(03)00242-8.

Article  Google Scholar 

Hildebrandt GC, Fazekas T, Lawitschka A, Bertz H, Greinix H, Halter J, et al. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transpl. 2011;46:1283–95. https://doi.org/10.1038/bmt.2011.35.

Article  CAS  Google Scholar 

Williams KM, Chien JW, Gladwin MT, Pavletic SZ. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA. 2009;302:306–14. https://doi.org/10.1001/jama.2009.1018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yan CH, Xu LP, Wang FR, Chen H, Han W, Wang Y, et al. Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transpl. 2016;51:391–7. https://doi.org/10.1038/bmt.2015.306.

Article  CAS  Google Scholar 

Lai YR, Chen YH, Hu DM, Jiang M, Liu QF, Liu L, et al. Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG). J Hematol Oncol. 2014;7:59. https://doi.org/10.1186/s13045-014-0059-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transpl. 2006;38:291–7. https://doi.org/10.1038/sj.bmt.1705445.

Article  Google Scholar 

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Biol Blood Marrow Transpl. 2009;15:257–65. https://doi.org/10.1016/j.bbmt.2008.11.025.

Article  CAS  Google Scholar 

Wu J, Fu HX, He Y, Mo XD, Liu X, Cai X, et al. Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl. 2021;56:2097–107. https://doi.org/10.1038/s41409-021-01293-y.

Article  CAS  Google Scholar 

Cai X, Fu HX, Mo XD, Wang Y, Zhang YY, Wu J, et al. Comparison of hemorrhagic and ischemic stroke after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2020;55:2087–97. https://doi.org/10.1038/s41409-020-0903-8.

Article  CAS  Google Scholar 

Sun X, Su Y, Liu X, Zhang Y, He Y, Han W, et al. Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models. Bone Marrow Transpl. 2021;56:1341–51. https://doi.org/10.1038/s41409-020-01187-5.

Article  Google Scholar 

Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD Grading. Bone Marrow Transpl. 1995;15:825–8.

CAS  Google Scholar 

Revilla-Lopez E, Berastegui C, Saez-Gimenez B, Lopez-Meseguer M, Monforte V, Bravo C, et al. Lung retransplantation due to chronic lung allograph dysfunction: results from a spanish transplant unit. Arch Bronconeumol. 2019;55:134–8. https://doi.org/10.1016/j.arbres.2018.07.025.

Article  PubMed  Google Scholar 

Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J. 2007;29:1007–19. https://doi.org/10.1183/09031936.00052806.

Article  CAS  PubMed  Google Scholar 

Erard V, Chien JW, Kim HW, Nichols WG, Flowers ME, Martin PJ, et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis. 2006;193:1619–25. https://doi.org/10.1086/504268.

Article  PubMed  Google Scholar 

Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Nichols WG, et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2003;168:208–14. https://doi.org/10.1164/rccm.200212-1468OC.

Article  PubMed  Google Scholar 

Ahn JH, Jo KW, Song JW, Shim TS, Lee SW, Lee JS, et al. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Clin Transpl. 2015;29:1133–9. https://doi.org/10.1111/ctr.12638.

Article  Google Scholar 

Kemp R, Pustulka I, Boerner G, Smela B, Hofstetter E, Sabeva Y, et al. Relationship between FEV(1) decline and mortality in patients with bronchiolitis obliterans syndrome-a systematic literature review. Respir Med. 2021;188:106608. https://doi.org/10.1016/j.rmed.2021.106608.

Article  PubMed  Google Scholar